# US 2014/0193912 A1 · Method for increasing the efficiency of inducing pluripotent stem cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0193912 A1
- Document ID: US20140193912A1
- Status: Published application
- Kind: A1
- Application number: 14/011,714
- Filed: 2013-08-27
- Published: 2014-07-10
- Earliest claimed: 2013-01-06
- Assignees: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
- Applicants: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
- Inventors: Duanqing PEI; Tao WANG
- Web page: https://patentgrep.com/patent/US20140193912A1

## CPC

- C12N 5/0696: {Artificially induced pluripotent stem cells, e.g. iPS}
- C12N 2500/38: Vitamins
- C12N 2501/603: Oct-3/4
- C12N 2501/604: Klf-4
- C12N 2501/606: c-Myc
- C12N 2501/998: Proteins not provided for elsewhere
- C12N 2506/1307: from adult fibroblasts
- C12N 2510/00: Genetically modified cells
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a method for increasing the efficiency of inducing pluripotent stem cells by utilizing genes Jhdm1a that modify histone. By utilizing Jhdm1a, and a stem cell inducing factor, the present invention increases the efficiency of inducing pluripotent stem cells and increases the quality of induced pluripotent stem cells. The stem cell inducing factor is a combination of Oct4 and Klf4, or a combination of Sox2, Oct4, and Klf4, or a combination of Oct4 and Sox2, and Oct4 alone. The method further comprises exposing the cells to vitamin C, which further increases the efficiency of inducing pluripotent stem cells as compared with the case where no vitamin C is used. By using less stem cell reducing factors, the method of the present invention reduces the potential carcinogenicity, obtains a high inducing efficiency, and provides high-quality induced pluripotent stem cells capable of germ-line transmission.

## Claims

### Claim 1

A method for increasing the efficiency of inducing pluripotent stem cells, comprising the following steps:
a. transferring a transcription factor and Jhdm1a or Jhdm1b into mammalian adult cells which are then cultured in an inducing medium to induce pluripotent stem cell clones, wherein the mammalian adult cells are mouse embryonic fibroblasts, the inducing medium includes vitamin C, and the transcription factor is Oct4, or a combination of Oct4 and Sox2, or a combination of Oct4 and Klf4.

### Claim 2 (depends on 1)

The method for increasing the efficiency of inducing pluripotent stem cells of claim 1, further comprising step b: culturing and expanding the induced pluripotent stem cell clones in a stem cell culture medium which is the inducing medium as described in the step a.

### Claim 3 (depends on 2)

The method for increasing the efficiency of inducing pluripotent stem cells of claim 2, characterized in that the transferring of Jhdm1a or Jhdm1b into mammalian adult cells is achieved by incorporating a vector capable of expressing Jhdm1a into the cells.

### Claim 4 (depends on 3)

The method for increasing the efficiency of inducing pluripotent stem cells of claim 3, characterized in that the vector is a viral vector and a plasmid vector.

### Claim 5 (depends on 4)

The method for increasing the efficiency of inducing pluripotent stem cells of claim 4, characterized in that the viral vector is a retrovirus which is a pMXs vector.

### Claim 6

A method for increasing the efficiency of inducing pluripotent stem cells, comprising the following steps:
a. transferring a transcription factor and Jhdm1a and Jhdm1b into mammalian adult cells which are then cultured in an inducing medium to induce pluripotent stem cell clones, wherein the mammalian adult cells are mouse embryonic fibroblasts, the inducing medium includes vitamin C, and the transcription factor is Oct4, or a combination of Oct4 and Sox2, or a combination of Oct4 and Klf4.

### Claim 7 (depends on 6)

The method for increasing the efficiency of inducing pluripotent stem cells of claim 6, further comprising step b: culturing and expanding the induced pluripotent stem cell clones in a stem cell culture medium which is the inducing medium as described in the step a.

### Claim 8 (depends on 7)

The method for increasing the efficiency of inducing pluripotent stem cells of claim 7, characterized in that the transferring of Jhdm1a and Jhdm1b into mammalian adult cells is achieved by incorporating a vector capable of expressing Jhdm1a into the cells.

### Claim 9 (depends on 8)

The method for increasing the efficiency of inducing pluripotent stem cells of claim 8, characterized in that the vector is a viral vector and a plasmid vector.

### Claim 10 (depends on 9)

The method for increasing the efficiency of inducing pluripotent stem cells of claim 9, characterized in that the viral vector is a retrovirus which is a pMXs vector.

### Claim 11 (depends on 1)

The method for increasing the efficiency of inducing pluripotent stem cells of claim 1, characterized in inducing medium includes DMEM high glucose medium, 15% fetal bovine serum, 0.1 mM nonessential amino acid, 2 mML-glutamine, 1 mM sodium pyruvate, 55 μM β-mercaptoethanol, 50 U/mL penicillin, 50 μg/mL streptomycin, and 1000 U/ml leukemia inhibitory factor, and 50 μg/mL vitamin C.

### Claim 12 (depends on 2)

The method for increasing the efficiency of inducing pluripotent stem cells of claim 2, characterized in inducing medium includes DMEM high glucose medium, 15% fetal bovine serum, 0.1 mM nonessential amino acid, 2 mML-glutamine, 1 mM sodium pyruvate, 55 μM β-mercaptoethanol, 50 U/mL penicillin, 50 μg/mL streptomycin, and 1000 U/ml leukemia inhibitory factor, and 50 μg/mL vitamin C.

### Claim 13 (depends on 6)

The method for increasing the efficiency of inducing pluripotent stem cells of claim 6, characterized in inducing medium includes DMEM high glucose medium, 15% fetal bovine serum, 0.1 mM nonessential amino acid, 2 mML-glutamine, 1 mM sodium pyruvate, 55 μM β-mercaptoethanol, 50 U/mL penicillin, 50 μg/mL streptomycin, and 1000 U/ml leukemia inhibitory factor, and 50 μg/mL vitamin C.

### Claim 14 (depends on 7)

The method for increasing the efficiency of inducing pluripotent stem cells of claim 7, characterized in inducing medium includes DMEM high glucose medium, 15% fetal bovine serum, 0.1 mM nonessential amino acid, 2 mML-glutamine, 1 mM sodium pyruvate, 55 μM β-mercaptoethanol, 50 U/mL penicillin, 50 μg/mL streptomycin, and 1000 U/ml leukemia inhibitory factor, and 50 μg/mL vitamin C.
